Symmetry Investments’s Biohaven BHVN Stock Holding History

Symmetry Investments’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,793	Closed	-$413K	–	96
2022 Q3	$413K	Buy	+2,793	New	+$20.3K	0.09%	96

Other funds holding BHVN

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Symmetry Investments's BHVN Position: Q4 2022 in Review

Symmetry Investments sold out of Biohaven (BHVN) in Q4 2022, closing a stake of 2,793 shares — an estimated $413K sold.

Symmetry Investments first reported a position in BHVN in Q3 2022 and held it in 1 quarter. The position peaked at $413K in Q3 2022. 176 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

Symmetry Investments reported no remaining Biohaven position as of Q4 2022 after selling out during the quarter.
Symmetry Investments sold 2,793 Biohaven shares in Q4 2022, an estimated $413K.
Symmetry Investments first reported a position in Biohaven in Q3 2022 and held it in 1 quarter.
Symmetry Investments's Biohaven position peaked at $413K in Q3 2022.
176 funds tracked by Wall St. Rank held Biohaven as of Q4 2022.

Based on Symmetry Investments's 13F filing for Q4 2022, filed 6 Feb 2023.